Alzeheimer's Disease Archives

Alzheimer’s disease is an incapacitating, progressive brain disorder that affects the lives of more than 6.5 million Americans. PamelaJoeMcFarlane/E+ via Getty Images James E. Galvin, University of Miami The U.S. Food and Drug Administration approved the medication lecanemab, sold under the brand name Leqembi, on Jan. 6, 2023, through an “accelerated approval pathway” that fast-tracks […]

Tag: Alzeheimer’s Disease

What the FDA’s accelerated approval of a new Alzheimer’s drug could mean for those with the disease – 5 questions answered about lecanemab

Alzheimer’s drug that modestly slows disease OK’d by FDA

Stalked by the fear that dementia is stalking you

New details emerge on drug that may slow Alzheimer’s disease

Blood tests for Alzheimer’s: Two experts on why new studies are encouraging

New clues on why women’s Alzheimer’s risk differs from men’s

Weakness for scams may be warning sign of dementia

States Push For Caregiver Tax Credits

Simple Eye Exam Could Lead to Early Alzheimer’s Diagnosis

Listening in to brain communications, without surgery

Assisted Living’s Breakneck Growth Leaves Safety Of Dementia Patients Behind

Unlocked And Loaded: Families Confront Dementia And Guns

Improving the lives of those with dementia – by using memories of baseball

Sign In